Spero Therapeutics SPRO
NASDAQ SPRO
$1.17 -0.05 (-4.10%)
At close: Oct 21, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Return on Equity [ROE] (2017 - 2026)

Updated

Spero Therapeutics (SPRO) posted Return on Equity [ROE] of 15.22% for Q2 2026, up 176.22 percentage points from -161.00% a year earlier but down 12.01 percentage points from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Return on Equity [ROE] (2017 - 2026) Analysis & Trends

For FY2025, Spero Therapeutics' Return on Equity [ROE] came in at 16.36%, up 106.02 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +92.13 percentage points (FY2020 to FY2025).
  • In prior years, Spero Therapeutics' Return on Equity [ROE] was -89.66% in FY2024 (-114.61 pp), 24.95% in FY2023 (+81.47 pp), -56.53% in FY2022 (+24.99 pp) and -81.51% in FY2021 (-5.74 pp).
  • Quarterly Return on Equity [ROE] has run from a low of -299.59% in Q3 2022 to a high of 28.42% in Q4 2023 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has increased in each of the last three quarters, with an average year-over-year change of -19.21 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2023, with a gain of 296.61 percentage points; the weakest was Q3 2022, with a drop of 221.33 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 27.23% (Q1 2026), 19.99% (Q4 2025) and -148.01% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.32%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 7.21%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.52%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 21.39%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 83.75%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -18.38%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 4.97%
10 Spero Therapeutics 68.40 Mn -127.38 Mn - 15.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.22%
Mar 31, 2026 27.23%
Dec 31, 2025 19.99%
Sep 30, 2025 -148.01%
Jun 30, 2025 -161.00%
Mar 31, 2025 -174.76%
Dec 31, 2024 -122.99%
Sep 30, 2024 4.74%
Jun 30, 2024 19.69%
Mar 31, 2024 23.03%
Dec 31, 2023 28.42%
Sep 30, 2023 -2.98%
Jun 30, 2023 -16.86%
Mar 31, 2023 -38.15%
Dec 31, 2022 -85.62%
Sep 30, 2022 -299.59%
Jun 30, 2022 -230.33%
Mar 31, 2022 -136.91%
Dec 31, 2021 -89.72%
Sep 30, 2021 -78.26%
API Access

Spero Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SPRO&period=max&api_key=YOUR_API_KEY